Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer

Figure 4

Validation of the FRlncRNAs signature for BC patients in the testing set and overall set. K-M curves showed that the high-risk group had the worse OS than the low-risk group in the testing set (a) and overall set (c). ROC curves and its AUC value in the testing set (b) and overall set (d). ROC curves and their AUC value represented 1-, 3-, and 5-year OS in the testing set (e) and overall set (g). Heatmap of 13 FRlncRNAs profiles showed the expression of FRlncRNAs in the high-risk group and the low-risk group in the testing set (f) and overall set (h). Scatter plot showed the outcomes between the survival status and risk score in the testing set (i) and overall set (j). Risk score distribution plot showed the distribution of high-risk and low-risk BC patients in the testing set (k) and overall set (l).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)